Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015

Abstract

mation on clinical features and outcomes of patients, except for death, was unavailable, and we could not determine prognostic factors for recent JE cases. Because details of each patient’s travel history was not identified, we could not clearly understand the mechanism of JEV transmission. In addition, we do not explore the possible cause of JE reemergence. Moreover, although JE incidence was detected by the national surveillance system, incidence might be underestimated because the database identified only serologically confirmed cases. JE vaccination is presumed to have failed to induce lifelong immunity so that older age groups become susceptible again. Further research is warranted to determine the long-term protection against JEV after primary vaccination. Moreover, future studies should address the need for booster vaccination for adults to maintain immunity against JEV.

DOI: 10.3201/eid2210.160357

Extracted Key Phrases

Cite this paper

@inproceedings{Bttcher2016RecombinantEA, title={Recombinant Enterovirus A71 Subgenogroup C1 Strains, Germany, 2015 }, author={Sindy B{\"{o}ttcher and Patrick E. Obermeier and Katrin Neubauer and Sabine M Diedrich}, booktitle={Emerging infectious diseases}, year={2016} }